Comparing an Electronic Decision Aid to Genetic Counseling for Genetic Testing in Ovarian and Pancreatic Cancer Patients

What this Trial Is About

Researchers are evaluating the effectiveness of an electronic decision aid tool compared to traditional genetic counselor sessions for multi-gene panel testing in people diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma. This randomized study is supported by the National Cancer Institute and aims to help patients better understand genetic testing options and support shared decision making. Participants are randomly assigned to one of two groups one group uses the electronic decision aid followed by an appointment with their oncologist, while the other receives pretest counseling from a genetic counselor. Both groups complete several questionnaires including a Knowledge Survey, Shared Decision Making Process Survey, and Decisional Conflict Scale. The study duration is up to two weeks. During the study, participants complete surveys before and about one week after their genetics sessions to assess knowledge, decision conflict, and shared decision making. Researchers also track the time between genetic testing recommendation and sample collection, the duration of the decision-making process, and choices made regarding genetic testing panels. Approximately 350 people are expected to participate in this research.

Genetic Testing Decision Aid